New Caledonia vs Tonga: The number of people with susceptibility test result for rifampicin
New Caledonia
100
in 2021
Tonga
100
in 2021
New Caledonia rank
2nd
Tonga rank
2nd
The number of people with susceptibility test result for rifampicin over time
- New Caledonia
- Tonga
How they compare
New Caledonia currently reports 100 against 100 in Tonga, a difference of 0.
Across all 5 years both countries report, Tonga has been ahead every year.
New Caledonia ranks 2nd and Tonga ranks 2nd of 146 countries.
Head to head by decade
| Decade | New Caledonia | Tonga | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 100 | 100 | 0 | — |
| 2020s | 100 | 100 | 0 | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, New Caledonia or Tonga?
- New Caledonia, at 100 against 100 in Tonga as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between New Caledonia and Tonga?
- 0, with New Caledonia ahead.
- How many years of comparable data are there for New Caledonia and Tonga?
- 5 years are reported by both, from 2017 to 2021.
- How do New Caledonia and Tonga rank globally for the number of people with susceptibility test result for rifampicin?
- New Caledonia ranks 2nd and Tonga ranks 2nd of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.